New treatment perspectives in autism spectrum disorders / / topic editors Roberto Canitano and Yuri Bozzi.
Developing novel and more effective treatments that improve quality of life for individuals with autism spectrum disorders is urgently needed. To date a wide range of behavioral interventions have been shown to be safe and effective for improving language and cognition and adaptive behavior in child...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | France : : Frontiers Media SA,, 2015 |
Year of Publication: | 2015 |
Language: | English |
Series: | Frontiers Research Topics.
|
Physical Description: | 1 online resource (161 pages) :; illustrations; digital file(s). |
Notes: | Bibliographic Level Mode of Issuance: Monograph |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993547726204498 |
---|---|
ctrlnum |
(CKB)3710000000526097 (SSID)ssj0001683379 (PQKBManifestationID)16509481 (PQKBTitleCode)TC0001683379 (PQKBWorkID)15037927 (PQKB)10367888 (WaSeSS)IndRDA00056714 (EXLCZ)993710000000526097 |
collection |
bib_alma |
record_format |
marc |
spelling |
New treatment perspectives in autism spectrum disorders / topic editors Roberto Canitano and Yuri Bozzi. France : Frontiers Media SA, 2015 1 online resource (161 pages) : illustrations; digital file(s). text txt rdacontent computer c rdamedia online resource cr rdacarrier text file rda Frontiers Research Topics Bibliographic Level Mode of Issuance: Monograph English Includes bibliographical references. Developing novel and more effective treatments that improve quality of life for individuals with autism spectrum disorders is urgently needed. To date a wide range of behavioral interventions have been shown to be safe and effective for improving language and cognition and adaptive behavior in children and adolescents with ASD. However many people with ASD can receive additional benefit from targeted pharmacological interventions. One of the major drawback in setting up therapeutics intervention is the remarkable individual differences found across individuals with ASD. As a matter of fact the medications that are currently available address only symptoms associated with ASD and not the core domains of social and communication dysfunction. The pathogenesis paradigm shift of ASD towards synaptic abnormalities moved the research to pathway to disease that involve multiple systems and that are becoming the forefront of ASD treatment and are pointing toward the development of new targeted treatments. Some new therapeutics have been tested and others are being studied. In this context single gene disorders frequently associated with ASD such as Rett Syndrome, Fragile X and Tuberous Sclerosis have been of significant aid as neurobiology of these disorders is more clear and has a potential to shed light on the altered signalling in ASD. However much research is needed to further understand the basic mechanisms of disease and the relationship to idiopathic ASD. Clinical trials in children are underway with agents directed to core symptoms and to the associated disorders in the search of new therapeutics and progress are expected with possible new option for therapeutics in ASD in the upcoming future. Children and Adolescents with ASD and their families can provide important information about their experience with new treatments and this should be a priority for future research. In addition, research performed on genetic mouse models of ASD will keep on providing useful information on the molecular pathways disrupted in the disease, thus contributing to identify novel drug targets. Pediatrics HILCC Medicine HILCC Health & Biological Sciences HILCC Bozzi, Yuri editor. Canitano, Roberto editor. Frontiers Research Topics. |
language |
English |
format |
eBook |
author2 |
Bozzi, Yuri Canitano, Roberto |
author_facet |
Bozzi, Yuri Canitano, Roberto |
author2_variant |
y b yb r c rc |
author2_role |
TeilnehmendeR TeilnehmendeR |
title |
New treatment perspectives in autism spectrum disorders / |
spellingShingle |
New treatment perspectives in autism spectrum disorders / Frontiers Research Topics |
title_full |
New treatment perspectives in autism spectrum disorders / topic editors Roberto Canitano and Yuri Bozzi. |
title_fullStr |
New treatment perspectives in autism spectrum disorders / topic editors Roberto Canitano and Yuri Bozzi. |
title_full_unstemmed |
New treatment perspectives in autism spectrum disorders / topic editors Roberto Canitano and Yuri Bozzi. |
title_auth |
New treatment perspectives in autism spectrum disorders / |
title_new |
New treatment perspectives in autism spectrum disorders / |
title_sort |
new treatment perspectives in autism spectrum disorders / |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA, |
publishDate |
2015 |
physical |
1 online resource (161 pages) : illustrations; digital file(s). |
isbn |
9782889193080 |
callnumber-first |
R - Medicine |
callnumber-subject |
RJ - Pediatrics |
callnumber-label |
RJ506 |
callnumber-sort |
RJ 3506 A9 |
illustrated |
Illustrated |
work_keys_str_mv |
AT bozziyuri newtreatmentperspectivesinautismspectrumdisorders AT canitanoroberto newtreatmentperspectivesinautismspectrumdisorders |
status_str |
n |
ids_txt_mv |
(CKB)3710000000526097 (SSID)ssj0001683379 (PQKBManifestationID)16509481 (PQKBTitleCode)TC0001683379 (PQKBWorkID)15037927 (PQKB)10367888 (WaSeSS)IndRDA00056714 (EXLCZ)993710000000526097 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
New treatment perspectives in autism spectrum disorders / |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796649023825772545 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03552nam a2200433 i 4500</leader><controlfield tag="001">993547726204498</controlfield><controlfield tag="005">20230621135630.0</controlfield><controlfield tag="006">m o u </controlfield><controlfield tag="007">cr#||#||||||||</controlfield><controlfield tag="008">160829s2015 fr a ob 001 | eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9782889193080</subfield><subfield code="q">(ebook)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3710000000526097</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SSID)ssj0001683379</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBManifestationID)16509481</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBTitleCode)TC0001683379</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBWorkID)15037927</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKB)10367888</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(WaSeSS)IndRDA00056714</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993710000000526097</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">PQKB</subfield><subfield code="b">eng</subfield><subfield code="d">UkMaJRU</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RJ506.A9</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">New treatment perspectives in autism spectrum disorders /</subfield><subfield code="c">topic editors Roberto Canitano and Yuri Bozzi.</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="a">France :</subfield><subfield code="b">Frontiers Media SA,</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (161 pages) :</subfield><subfield code="b">illustrations; digital file(s).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Bibliographic Level Mode of Issuance: Monograph</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Developing novel and more effective treatments that improve quality of life for individuals with autism spectrum disorders is urgently needed. To date a wide range of behavioral interventions have been shown to be safe and effective for improving language and cognition and adaptive behavior in children and adolescents with ASD. However many people with ASD can receive additional benefit from targeted pharmacological interventions. One of the major drawback in setting up therapeutics intervention is the remarkable individual differences found across individuals with ASD. As a matter of fact the medications that are currently available address only symptoms associated with ASD and not the core domains of social and communication dysfunction. The pathogenesis paradigm shift of ASD towards synaptic abnormalities moved the research to pathway to disease that involve multiple systems and that are becoming the forefront of ASD treatment and are pointing toward the development of new targeted treatments. Some new therapeutics have been tested and others are being studied. In this context single gene disorders frequently associated with ASD such as Rett Syndrome, Fragile X and Tuberous Sclerosis have been of significant aid as neurobiology of these disorders is more clear and has a potential to shed light on the altered signalling in ASD. However much research is needed to further understand the basic mechanisms of disease and the relationship to idiopathic ASD. Clinical trials in children are underway with agents directed to core symptoms and to the associated disorders in the search of new therapeutics and progress are expected with possible new option for therapeutics in ASD in the upcoming future. Children and Adolescents with ASD and their families can provide important information about their experience with new treatments and this should be a priority for future research. In addition, research performed on genetic mouse models of ASD will keep on providing useful information on the molecular pathways disrupted in the disease, thus contributing to identify novel drug targets.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatrics</subfield><subfield code="2">HILCC</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">HILCC</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Health & Biological Sciences</subfield><subfield code="2">HILCC</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bozzi, Yuri</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Canitano, Roberto</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Frontiers Research Topics.</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-25 10:44:26 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2015-12-12 16:57:58 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338660410004498&Force_direct=true</subfield><subfield code="Z">5338660410004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338660410004498</subfield></datafield></record></collection> |